Showing results (811-820 of 2,625) with videos related to
Sort By:
Pageof 263
Journal of Ginseng Research|November 8, 2019
AKT1-targeted proapoptotic activity of compound K in human breast cancer cellsEunju Choi, Eunji Kim, Ji Hye Kim, et al.Cell Reports Methods|July 5, 2022
Development of an HIV reporter virus that identifies latently infected CD4+ T cellsEun Hye Kim, Lara Manganaro, Michael Schotsaert, et al.Human Vaccines & Immunotherapeutics|April 20, 2021
Natural killer cells contribute to enhanced respiratory disease after oil-in-water emulsion adjuvanted vaccination against respiratory syncytial virus and infectionYoonsuh Park, Ki-Hye Kim, Youri Lee, et al.Endocrine Connections|January 11, 2022
Phenotypic spectrum of patients with mutations in CHD7: clinical implications of endocrinological findingsJa Hye Kim, Yunha Choi, Soojin Hwang, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 8, 2015
Alzheimer's in 3D culture: challenges and perspectivesCarla D'Avanzo, Jenna Aronson, Young Hye Kim, et al.Plos One|June 29, 2016
Pre-Treatment Objective Diagnosis and Post-Treatment Outcome Evaluation in Patients with Vascular Pulsatile Tinnitus Using Transcanal Recording and Spectro-Temporal AnalysisShin Hye Kim, Gwang Seok An, Inyong Choi, et al.Annals of Pediatric Endocrinology & Metabolism|October 28, 2014
Long-term follow-up on Cushing disease patient after transsphenoidal surgeryInsook Jeong, Moonyeon Oh, Ja Hye Kim, et al.Biochemical and Biophysical Research Communications|June 19, 2017
WITHDRAWN: Ameloblast-like characteristics of human Hertwig's epithelial rest of Malassez/epithelial rest of Malassez cells via interaction with stem cells from human exfoliated deciduous teethHyun Nam, Gee-Hye Kim, Jae-Won Kim, et al.Plos One|October 3, 2012
Interleukin 27 induces the expression of complement factor H (CFH) in the retinaAhjoku Amadi-Obi, Cheng-Rong Yu, Ivy Dambuza, et al.Journal of Cancer Research and Clinical Oncology|July 10, 2012
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapyYoungjoo Lee, Sun Hye Kim, Ji-Youn Han, et al.Pageof 263